Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Global osteoporosis drug market share 2014-2022, by drug type

Osteoporosis drug market share worldwide from 2014 to 2022, by drug type

by Matej Mikulic, last edited Jan 29, 2019
Global osteoporosis drug market share 2014-2022, by drug type This statistic presents the share of the osteoporosis drug market worldwide in 2014 and 2015, with forecasts to 2022, by drug type. In 2015, the osteoporosis drug market was worth around 8.8 billion U.S. dollars, with calcitonin drugs accounting for some 4.6 percent of this total.
Show more

Osteoporosis drug market share worldwide from 2014 to 2022, by drug type

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Global pharmaceutical industry"
  • Overview
The most important statistics
  • Companies and products
  • Top companies by revenue
  • R&D, patents, new products
  • Outlook
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.